Charles River Laboratories International (CRL) news

Mizuho raises target price to $264 from $230 for Charles River Laboratories International, Inc.

Mizuho Securities has raised its price target for Charles River Laboratories International, Inc. (NYSE: CRL) to $192 from $172, while maintaining a Neutral rating . The adjustment follows the company’s strong first-quarter 2026 performance, which included revenue of $996 million—2% above consensus…

TD Cowen raises target price to $300 from $235 for Charles River Laboratories International, Inc.

TD Cowen has raised its price target for Charles River Laboratories International, Inc. (NYSE: CRL) to $300 from $235, while maintaining its "Buy" rating . This adjustment reflects the firm’s continued confidence in the company’s long-term strategic initiatives and potential for value creation. The…

Charles River Laboratories International, Inc.: Jefferies raises target price to $305 from $225

RBC raises target price to $282 from $215 for Charles River Laboratories International, Inc.

Charles River exec says well positioned to support our acquisition strategy, we'd love to be able to add a couple additional companies to our portfolio - conf call

Charles River Laboratories is currently refining its portfolio and strengthening its financial position to support future growth opportunities, including strategic acquisitions. As part of its ongoing strategic review, the company has announced plans to divest certain underperforming or non-core…